Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268]
Titel:
Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268]
Auteur:
Allard, Sabine D. De Keersmaecker, Brenda de Goede, Anna L. Verschuren, Esther J. Koetsveld, Jeanette Reedijk, Mariska L. Wylock, Carolien De Bel, Annelies V. Vandeloo, Judith Pistoor, Frank Heirman, Carlo Beyer, Walter E.P. Eilers, Paul H.C. Corthals, Jurgen Padmos, Iman Thielemans, Kris Osterhaus, Albert D.M.E. Lacor, Patrick van der Ende, Marchina E. Aerts, Joeri L. van Baalen, Carel A. Gruters, Rob A.